Close
Back to AXON Stock Lookup

Axon (AXON) – Hot FDA News

Jan 8, 2018 07:01 AM Axovant Sciences (AXON) Says Intepirdine Did Not Meet its Primary Efficacy Endpoints in Phase 2b HEADWAY and pilot Phase 2 Gait and Balance Studies
Sep 26, 2017 07:02 AM Axovant (AXON) Says its Intepirdine Phase 3 MINDSET Trial in AD Did Not Meet its co-Primary Efficacy Endpoints
Jul 19, 2017 08:11 AM
Jun 19, 2017 07:01 AM

Back to AXON Stock Lookup